Block of Intercostobrachial Nerve
Conditions
Interventions
Test group:the first patient received a volume of 5 ml of 0.5% ropivacaine, this volume was decreased or increased by 0.5ml, depending on whether the block had been successful or unsuccessful, respect
Sponsors
Department of Anesthesiology and Perioperative Medicine, Luoyang Orthopedic Hospital of Henan Province Orthopedic Hospital of Henan Province.
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: ?patients undergoing surgery of the upper limb (hand, forearm, elbow, and the upper arm) ? aged 18 to 60 years ?with a body mass index (BMI) between 18 and 30 kg/m2 ? American Society of Anesthesiologists (ASA) physical status I or II
Exclusion criteria
Exclusion criteria: ?patients with known peripheral neuropathy, known polyneuropathy, known myopathy ? those who had been undergoing previous surgery that involved the axillary region ?allergic to local anesthetics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation criteria for effectiveness: intercostal brachial nerve block was evaluated every 3 minutes 30 minutes after injection; | — |
Secondary
| Measure | Time frame |
|---|---|
| the time of blocking operation (from the time of contact with the ultrasound probe to the end of local anesthetic injection) ;Complications were followed up for 2 days after the block, including local anesthetic intoxication, hematoma infection at the puncture site, numbness or tingling at the blocked site.;the time of blocking effect. ; | — |
Countries
China
Contacts
Public ContactWenchao Chen
LuoYang Orthopedic Hospital of Henan Province.Orthopedic Hospital of Henan Province
Outcome results
None listed